advancing innovation to save lives

GHTC honors Sen. Coons, Cong. Cole, and the dapivirine microbicide ring with Innovating for Impact Awards

GHTC’s hosted the Innovating for Impact Awards to celebrate US commitment to global health research and development (R&D) and recognize the policymakers and partnerships driving progress in global health innovation.
Learn More

The first step

GHTC released a new two-minute video taking viewers on a journey to discover how sustained investments in global health R&D can unlock health and opportunity for people around the world.

Member spotlight

RESULTS performs cutting-edge research and oversight; educates and mobilizes the public, policy makers, and the media; and supports powerful citizenship by training volunteers in advocacy, including on global health.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
GHTC honors Senator Coons, Congressman Cole, and the dapivirine microbicide ring with Innovating for Impact Awards

Esteemed leaders from across the US government, industry, and the global health and medical research communities gathered at the Newseum in Washington, DC yesterday for GHTC’s Innovating for Impact Awards to celebrate US commitment to global health research and development (R&D) and recognize Senator Chris Coons (D-DE) and Congressman Tom Cole (R-OK) for their congressional leadership on this issue. GHTC also honored the partnership that developed the dapivirine microbicide ring—a woman-centered HIV prevention tool—for its efforts to advance this groundbreaking new technology.

Learn More
PATH/Patrick McKern
GHTC featured in Devex Twitter chat recap

Tweets by GHTC were featured in Devex's #Health4Security Twitter chat recap, which aimed to discuss US leadership and investment in health for security. 

View All News & Events

Member Event

PATH/Gabe Bienczycki
Webinar: Exploring the implications of the delamanid phase III and STREAM trial results
Learn More

Member Event

PATH/Gabe Bienczycki
5th Global Forum on TB Vaccines
Stop TB Partnership, Aeras, TBVI, THSTi...
Learn More
View All Events
President Obama emphasizes innovation and research in State of the Union

Ashley Bennett, senior policy associate at the GHTC, offered her take on President Obama’s State of the Union address, including his emphasis on research and innovation, after listening to him deliver the speech earlier this week.

Read More
PATH/Evelyn Hockstein
Global health R&D in the US: Smart for California, right for the world

Global health research not only has the potential to save lives and prevent disabilities, it is good business. And Californians agree. A clear majority—58%—agree that global health research is important to the state’s economy, and 70% agree that Americans would be better off if the United States invests in global health research.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide